摘要 |
Formulations are provided, comprising: a compound of Formula (I), a pharmaceutically acceptable salt thereof, or a mixture of any two or more thereof; and an ingredient selected from a hydrophilic solvent, a lipophilic solvent, an emulsifier, or a mixture of any two or more thereof; wherein the compound of Formula (I) is: In some embodiments, the formulations are liquids. In other embodiments, the formulations are solids. Also provided are methods of preparing such formulations. |
申请人 |
NOVARTIS AG;HASHASH, AHMAD;RITCHIE, SEAN;LIN, KANGWEN;SHEN, PENG;OKHAMAFE, AUGUSTUS;GULLAPALLI, RAMPURNA |
发明人 |
HASHASH, AHMAD;RITCHIE, SEAN;LIN, KANGWEN;SHEN, PENG;OKHAMAFE, AUGUSTUS;GULLAPALLI, RAMPURNA |